News
When the Industrial Revolution took place in 1760, millions of people lost their jobs. This era saw the rise of factories and ...
Roche Pharma India partners with government hospitals to train professionals on GCP standards, addressing clinical trial ...
Roche Pharma partners with 10 government hospitals in India to strengthen clinical trial capabilities. Training provided to 400+ professionals.
Oracle's growth signals the end of experimental AI and urgent need for enterprises to secure production infrastructure now.
The pharmaceutical industry is evolving at a rapid pace, with new technologies, stricter regulations, and advanced therapies reshaping the future of healthcare.
In a major step to boost clinical research in India, government hospitals are partnering with Roche Pharma India to strengthen their capacity to conduct clinical trials. Roche Pharma India also on ...
India accounts for 17% of the world’s population and 20% of the global disease burden, yet fewer than four percent of ...
Roche partners with 10 government hospitals to strengthen clinical trial capabilities in India: Our Bureau, Bengaluru Monday, September 15, 2025, 12:10 Hrs [IST] Roche Pharma Indi ...
Oracle's cloud and AI-driven growth surge despite Q1 earnings miss. Find out why I recommend waiting for a better entry point ...
Zacks Investment Research on MSN
Is IonQ the NVIDIA of Tomorrow, and Should You Buy the Stock?
The way NVIDIA Corporation NVDA benefited from the artificial intelligence (AI) boom to become a $4 trillion behemoth, a ...
Investor's Business Daily on MSN
Oracle's AI Gains 'Are Clear.' Here's How Its Cloud Stacks Up Against Amazon, Microsoft, Google.
Oracle stock got a massive boost last week from the cloud growth forecast it gave with its fiscal first-quarter results.
Zacks highlights NVIDIA, IonQ, Amazon, Microsoft, and Alphabet, focusing on IonQ's potential as a quantum computing leader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results